Suppr超能文献

将股静脉用作带隧道血液透析导管的插入部位。

Use of the femoral vein as insertion site for tunneled hemodialysis catheters.

作者信息

Falk Abigail

机构信息

American Access Care, 200 Boston Avenue, Medford, Massachusetts 02155, USA.

出版信息

J Vasc Interv Radiol. 2007 Feb;18(2):217-25. doi: 10.1016/j.jvir.2006.12.001.

Abstract

PURPOSE

To determine the outcome of tunneled hemodialysis catheters inserted through the common femoral vein.

MATERIALS AND METHODS

From April 2000 to June 2003, 33 consecutive patients had 86 tunneled hemodialysis catheters inserted through the femoral vein. There were 14 male and 19 female patients with a mean age of 56 years. Seventeen patients had bilateral central venous and/or superior vena cava (SVC) occlusions, 12 patients had unilateral central venous occlusions and were to receive contralateral arteriovenous fistulas or arteriovenous polytetrafluoroethylene grafts, and 4 patients received femoral catheters for other reasons. The technical success, complications, and clinical outcomes of these procedures were retrospectively evaluated.

RESULTS

All procedures were technically successful. Fifty-seven catheters were inserted into the right femoral vein and 29 into the left femoral vein. This included 25 catheter exchanges in 13 patients. Two patients developed thigh hematomas. Follow-up data were available for 68 catheters; mean follow-up period was 51 days with a total of 3,484 catheter days. The catheter-related infection rate was 6.3 per 1,000 catheter days; 22 catheters were removed for infection. Eighteen catheters were removed because of poor blood flows (<200 mL/min). Thirteen catheters were removed because they had become retracted. Primary catheter patency was 44% at 1 month.

CONCLUSIONS

The femoral vein provides an alternative access site for insertion of tunneled hemodialysis catheters when conventional sites are not available. However, tunneled femoral hemodialysis catheters have low primary patency rates and significant complications. Catheter retraction is a unique and common problem.

摘要

目的

确定经股总静脉置入带隧道的血液透析导管的结果。

材料与方法

2000年4月至2003年6月,33例患者连续置入86根经股静脉带隧道的血液透析导管。其中男性14例,女性19例,平均年龄56岁。17例患者存在双侧中心静脉和/或上腔静脉(SVC)闭塞,12例患者存在单侧中心静脉闭塞并计划接受对侧动静脉内瘘或动静脉聚四氟乙烯移植,4例患者因其他原因接受股静脉导管置入。对这些操作的技术成功率、并发症及临床结果进行回顾性评估。

结果

所有操作技术均成功。57根导管置入右股静脉,29根置入左股静脉。其中13例患者进行了25次导管更换。2例患者出现大腿血肿。68根导管有随访数据;平均随访期为51天,累计导管使用天数为3484天。导管相关感染率为每1000导管日6.3例;22根导管因感染被拔除。18根导管因血流量不佳(<200 mL/分钟)被拔除。13根导管因回缩被拔除。1个月时导管初始通畅率为44%。

结论

当常规置管部位不可用时,股静脉为置入带隧道的血液透析导管提供了一个替代置管部位。然而,经股静脉带隧道的血液透析导管初始通畅率较低且并发症严重。导管回缩是一个独特且常见的问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验